updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
Published 2 years ago • 507 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
2:21
clinical updates on the use of momelotinib for mpns
-
3:02
latest updates on momelotinib: safety, durability of response & survival benefit
-
3:00
the promise of momelotinib in the treatment of myelofibrosis
-
3:03
an insight into the momentum trial: safety and efficacy of momelotinib for the treatment of mf
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
6:00
most boys don't have adhd | jordan peterson
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
20:01
primary myelofibrosis - overview (presentation, pathophysiology, investigation, treatment)
-
4:15
the latest data on momelotinib for mpns
-
13:53
is your child misdiagnosed? dr. ronald leaf on the challenges of autism diagnosis. #autismdiagnosis
-
4:25
update on momelotinib for myelofibrosis
-
1:40
momelotinib for the treatment of myelofibrosis
-
1:44
momelotinib: a promising agent in mf
-
1:28
momelotinib in 2024: how should this agent be used in mf with anemia?
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:59
the optec study: evaluating outpatient step-up administration of teclistamab in pts with r/r myeloma
-
2:26
assessing the impact of momelotinib on transfusion burden in mf: analysis of simplify-1 & momentum
-
1:45
momelotinib vs soc in patients with mf and anemia: an analysis from the simplify-2 trial
-
1:24
updated results from the momentum study assessing the efficacy of momelotinib in mf
-
2:48
updated results from the momentum trial
-
1:04
long-term survival outcomes in pts with mf treated with momelotinib vs danazol in the momentum trial